Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 644. Отображено 100.
14-06-2012 дата публикации

PROCESS FOR THE PREPARATION OF 1-BENZYL-3-HYDROXYMETHYL-1H-INDAZOLE AND ITS DERIVATIVES AND REQUIRED MAGNESIUM INTERMEDIATES

Номер: US20120149912A1

The present invention relates to the process for the conversion of 1-benzyl-3-hydroxymethyl-1H-indazole according to formula (II), to the 1-benzyl-3-hydroxylmethyl-1H-indazole according to formula (I). 2. The process of preparation according to claim 1 , in which the said 1-benzyl-3-hydroxymethyl-1H-indazole represented by formula (I) are caused to form salts with the carboxyl group —COORby treatment with a pharmaceutically acceptable organic or inorganic base.3. The process of preparation according to wherein Rand R claim 1 , which may be the same or different claim 1 , are represented by a hydrogen atom claim 1 , or an alkyl group having 1 to 3 carbon atoms.4. The process of preparation according to wherein R claim 1 , Rand R claim 1 , which may be the same or different claim 1 , may be hydrogen claim 1 , a methyl group claim 1 , an ethyl group claim 1 , a methoxy group claim 1 , an ethoxy group claim 1 , a chlorine atom and a fluorine atom claim 1 ,5. The process of preparation according to wherein Rmay be hydrogen claim 1 , a methyl group claim 1 , an ethyl group claim 1 , a methoxy group claim 1 , an ethoxy group claim 1 , a chlorine atom and a fluorine atom claim 1 , or together with Rand Rmay form a ring having 6 carbon atoms claim 1 , and6. The process of preparation according to wherein Rand R claim 1 , which may be the same or different claim 1 , may be hydrogen claim 1 , a methyl group claim 1 , an ethyl group claim 1 , or one of Rand Rtogether with Rmay form a ring having 6 carbon atoms. This invention relates to a process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole.In particular, the present invention relates to the process for the conversion of 1-benzyl-3-hydroxymethyl-1H-indazole according to formula (II) below, to the 1-benzyl-3-hydroxymethyl-1H-indazole according to formula (I) below.European patent EP-B-0 382 276 describes some 1-benzyl-3-hydroxymethyl-1H-indazole derivatives of formula (A) having analgesic activity:in whichR and R ...

Подробнее
10-01-2013 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20130012520A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
08-08-2013 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20130203771A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29: A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30: A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31: A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32: A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33: A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34: A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35: A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
24-10-2013 дата публикации

STAR-AND TREE-SHAPED BRANCHED POLYMERS HAVING FLAME-RETARDANT PROPERTIES

Номер: US20130281654A1
Принадлежит: UNIVERSITA' DEGLI STUDI DI MILANO

Disclosed are polymers with a complex branched structure (star- or tree-shaped) obtainable by polymerizing a bifunctional type AB monomer and/or type AA+BB monomers in the presence of: a) one or more polyamine and/or a polyacid and/or a polyalcohol and/or more generally a compound (such as POSS) having at least three functional groups such as amino, carboxylic acid or hydroxyl functions; b) one or more phosphorus containing molecules reacting with only one reactive group during the polymerization; c) optionally one or more organic acid and/or an amine and/or an alcohol having one or two functional groups. 1. Branched polymers having a star- or tree-shaped structure obtainable by polymerisation of a bifunctional monomer of type AB and/or of monomers of type AA+BB in the presence of:A) one or more polyamines and/or polyacids and/or polyalcohols and/or Polyhedral Oligosilsequioxanes compounds (POSS) having at least three functional groups selected from primary and/or secondary amino functions and/or carboxylic acids or derivatives thereof and/or hydroxyl functions;B) one or more phosphorus containing molecules reacting with only one reactive group during the polymerization;C) optionally, one or more carboxylic acids (or their derivatives such as ester and anhydride) and/or amines and/or alcohols having one or two functional groups.2. Polymers as claimed in claim 1 , wherein monomer AB and monomers of type AA+BB have A=—COOH (or his derivative such as ester and anhydride) and B=—NHor —OH.3. Polymers as claimed in claim 2 , belonging to the class of polyamides and polyesters.4. Polyamides as claimed in claim 3 , wherein monomers AB are selected from caprolactam claim 3 , 6-amino-hexanoic acid claim 3 , para or meta amino benzoic acid claim 3 , 11-aminoundecanoic acid claim 3 , lauryl lactam claim 3 , 12-aminododecanoic acid claim 3 , and wherein monomers of type AA+BB are selected from: as AA monomer claim 3 , adipic acid claim 3 , suberic acid claim 3 , sebacic acid ...

Подробнее
31-10-2013 дата публикации

Vegetable oil derivatives as extender oils for elastomer compositions

Номер: US20130289182A1
Принадлежит: Novamont SpA

Elastomer composition comprising at least one elastomer and at least one vegetable oil derivative selected from one or more of: a. mixture of triglycerides comprising one or more of the following oligomeric structures: R4[OC(O)R 1 C(O)OCH 2 CH(OR 2 )CH 2] n OR 3 wherein R 1 is selected from C2-C22 alkylenes, R 2 is selected from one or more of the following groups consisting of C6-C24 dicarboxylic acid residues and C6-C24 monocarboxylic acid residues, R 3 is selected from one or more of the following groups consisting of H, C 6 -C 24 dicarboxylic acid residues and C 6 -C 24 monocarboxylic acid residues, R 4 is an alkyl group, n is an integer greater than or equal to 2, said C 6 -C 24 dicarboxylic acid residues of R 2 and R 3 being esterified with monoalcohols and said mixture of triglycerides having a Numerical Average Molecular Weight (Mn) of between 800 and 10.000. b. triglycerides of one or more long chain carboxylic acids including at least one carboxylic acid containing adjacent hydroxyl groups, c. esters of polyols with at least a monocarboxylic acid and at least a dicarboxylic acid, the said esters being other than triglycerides.

Подробнее
27-02-2014 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20140057922A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of allylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
14-01-2021 дата публикации

MACHINE LEARNING BASED GAZE ESTIMATION WITH CONFIDENCE

Номер: US20210011550A1
Принадлежит: Tobii AB

The disclosure relates to a method performed by a computer for identifying a space that a user of a gaze tracking system is viewing, the method comprising obtaining gaze tracking sensor data, generating gaze data comprising a probability distribution using the sensor data by processing the sensor data by a trained model and identifying a space that the user is viewing using the probability distribution. 1. A method performed by a computer for identifying a space that a user of a gaze tracking system is viewing , the method comprising:obtaining gaze tracking sensor data,generating gaze data comprising a probability distribution using the sensor data by processing the sensor data by a trained model,identifying a space that the user is viewing using the probability distribution.2. The method according to claim 1 , wherein the space comprises a region claim 1 , wherein the probability distribution is indicative of a plurality of regions claim 1 , each region having related confidence data indicative of a confidence level that the user is viewing the region.3. The method according to claim 2 , wherein the plurality of regions forms a grid representing a display the user is viewing.4. The method according to claim 2 , wherein identifying the space the user is viewing comprises selecting a region claim 2 , from the plurality of regions claim 2 , having the highest confidence level.5. The method according to claim 2 , further comprising determining a gaze point using the selected region claim 2 , e.g. determined as the geometric center of the region or center of mass of the region.6. The method according to claim 2 , wherein each region of the plurality of regions is arranged spatially separate and representing an object or a part of an object that the user is potentially viewing claim 2 , wherein said object is a real object or a part of a real object claim 2 , and/or a virtual object or a part of a virtual object.7. The method according to claim 6 , wherein identifying ...

Подробнее
14-01-2021 дата публикации

TRAINING AN EYE TRACKING MODEL

Номер: US20210012157A1
Принадлежит: Tobii AB

A method for training an eye tracking model is disclosed, as well as a corresponding system and storage medium. The eye tracking model is adapted to predict eye tracking data based on sensor data from a first eye tracking sensor. The method comprises receiving sensor data obtained by the first eye tracking sensor at a time instance and receiving reference eye tracking data for the time instance generated by an eye tracking system comprising a second eye tracking sensor. The reference eye tracking data is generated by the eye tracking system based on sensor data obtained by the second eye tracking sensor at the time instance. The method comprises training the eye tracking model based on the sensor data obtained by the first eye tracking sensor at the time instance and the generated reference eye tracking data. 1. A method for training an eye tracking model , wherein the eye tracking model is adapted to predict eye tracking data based on sensor data from a first eye tracking sensor , the method comprising:receiving sensor data obtained by the first eye tracking sensor at a time instance;receiving reference eye tracking data for said time instance generated by an eye tracking system comprising a second eye tracking sensor, wherein the reference eye tracking data is generated by the eye tracking system based on sensor data obtained by the second eye tracking sensor at said time instance; andtraining the eye tracking model based on the sensor data obtained by the first eye tracking sensor at said time instance and the generated reference eye tracking data.2. The method of claim 1 , further comprising:using the first eye tracking sensor to obtain sensor data at said time instance.3. The method of claim 1 , further comprising:using the eye tracking system to generate the reference eye tracking data for said time instance.4. The method of claim 1 ,wherein the eye tracking data predicted by the eye tracking model indicates a predicted gaze point of an eye, and wherein the ...

Подробнее
10-02-2022 дата публикации

GAZE TRACKING

Номер: US20220043509A1
Принадлежит: Tobii AB

A system configured to enable operation of an apparatus based on the gaze of a user, the system comprising a processor, and a memory comprising instructions executable by the processor, wherein the system is configured to determine a gaze region of a user among a plurality of regions associated with the apparatus, wherein the plurality of regions comprises at least one primary gaze region and at least one secondary gaze region and perform at least one action based on the determination of the gaze region, wherein the system is configured to determine the gaze region using a first gaze estimation algorithm and/or a second gaze estimation algorithm. 1. A system configured to enable operation of an apparatus based on the gaze of a user , the system comprising:a processor; and determine a gaze region of a user among a plurality of regions associated with the apparatus, wherein the plurality of regions comprises at least one primary gaze region and at least one secondary gaze region; and', 'perform at least one action based on the determination of the gaze region;', 'wherein the system is configured to determine the gaze region using a first gaze estimation algorithm and/or a second gaze estimation algorithm., 'a memory comprising instructions executable by the processor, wherein the system is configured to2. The system of claim 1 , wherein the system is configured to determine the gaze region using only the first gaze estimation algorithm.3. The system of claim 1 , further configured to:determine a gaze region using the first gaze estimation algorithm;determine a gaze region using the second gaze estimation algorithm; andselect either the gaze region determined by the first gaze estimation algorithm or the gaze region determined by the second gaze estimation algorithm.4. The system of claim 3 , wherein:the first and second gaze estimation algorithms are configured to yield respective confidence signals associated with their respective determined gaze regions; andif the ...

Подробнее
04-02-2021 дата публикации

CONTINUOUS PROCESS FOR THE PREPARATION OF TRAZODONE

Номер: US20210032243A1

The present invention relates to an improved process for the preparation of trazodone. In particular, the present invention relates to a continuous process for the preparation of trazodone. More in particular, the present invention relates to a new method for the preparation of trazodone, said method comprising at least one step consisting of a continuous process performed in a flow reactor. 2: The continuous process according to claim 1 , comprising:(i) continuously feeding a first channel of a flow reactor with an aqueous solution of s-triazolo-[4,3-a]-pyridin-3-one (III) and at least one basic compound;(ii) continuously feeding a second channel of said flow reactor with an organic solution of N-(3-chlorophenyl)-N′-(3-chloropropyl)-piperazine (II) in at least one organic solvent;(iii) continuously reacting said s-triazolo-[4,3-a]-pyridin-3-one (III) with said N-(3-chlorophenyl)-N′-(3-chloropropyl)-piperazine (II) by continuously mixing said alkaline aqueous solution and said organic solution in said flow reactor, at a temperature of at least 90° C.; and(iv) continuously collecting said reaction mixture from said flow reactor, and isolating the obtained product trazodone base (IV).3: The process according to claim 1 , wherein trazodone base (IV) is obtained with a conversion yield of at least 70% by HPLC.4: The process according to claim 1 , wherein trazodone base (IV) has a purity of at least 90% by HPLC.5. (canceled)6: The process according to claim 2 , wherein the temperature of said continuously reacting iii) is from 130° C. to 160° C.7: The process according to claim 2 , wherein said basic compound in said continuously feeding a first channel i) is an inorganic base selected from the group consisting of sodium hydroxide claim 2 , potassium hydroxide claim 2 , sodium hydride claim 2 , sodium amide claim 2 , sodium carbonate claim 2 , potassium carbonate claim 2 , sodium bicarbonate claim 2 , potassium bicarbonate claim 2 , sodium phosphate claim 2 , potassium ...

Подробнее
06-02-2020 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20200038396A1

A process of production of trazodone or trazodone hydrochloride that comprises; (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
25-02-2021 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20210052577A1

A process of production of trazodone or trazodone hydrochloride diet comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29: A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30: A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31: A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32: A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33: A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34: A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35: A pharmaceutical composition according to claim 29 , wherein said at least ...

Подробнее
25-02-2021 дата публикации

1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS

Номер: US20210053956A1

The present invention relates to the 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta (GSK-3β) inhibitors and to their use in the treatment of GSK-3β-related disorders such as, for example, (i) insulin-resistance disorders; (ii) neurodegenerative diseases; (iii) mood disorders; (iv) schizophrenic disorders; (v) cancerous disorders; (vi) inflammation, (vii) osteoporosis, (viii) cardiac hypertrophy, (ix) epilepsies and (x) neuropathic pain. 2: The 1H-indazole-3-carboxamide compound according to claim 1 , wherein Ris a carbocyclic or heterocyclic ring claim 1 , aliphatic or aromatic claim 1 , having from 4 to 10 members.3: The 1H-indazole-3-carboxamide compound according to claim 1 , wherein Ris a carbocyclic or heterocyclic ring claim 1 , aliphatic or aromatic claim 1 , having from 5 to 6 members.4: The 1H-indazole-3-carboxamide compound according to claim 1 , wherein Ris an aromatic carbocyclic or heterocyclic ring claim 1 , having 6 members.5: The 1H-indazole-3-carboxamide compound according to claim 1 , wherein Y is a bond or a C-Calkyl group.6: The 1H-indazole-3-carboxamide compound according to claim 1 , wherein Ris an aliphatic heterocyclic ring having from 5 to 6 members comprising at least one heteroatom selected from S and O.7: The 1H-indazole-3-carboxamide compound according to claim 1 , wherein Ris an aliphatic heterocyclic ring having from 5 to 6 members comprising at least one oxygen atom.8: The 1H-indazole-3-carboxamide compound according to claim 1 , wherein Ris a thiolanyl group claim 1 , a oxolanyl group claim 1 , a thianyl group or a oxanyl group.9: The 1H-indazole-3-carboxamide compound according to claim 1 , wherein Ris a 1 claim 1 ,1-dioxothiolanyl group claim 1 , a oxolanyl group or a oxanyl group.10: The 1H-indazole-3-carboxamide compound according to claim 1 , wherein said C-Calkyl amino is a C-Calkyl group wherein one or more hydrogen atom of the alkyl chain is substituted by an amino group having the formula —NRR claim 1 ...

Подробнее
14-02-2019 дата публикации

Sintered non-porous cathode and sputter ion vacuum pump containing the same

Номер: US20190051504A1
Принадлежит: SAES Getters SpA

The present invention relates to cathodes electrodes compositions suitable to provide a pumping mechanism which exhibits an extremely high pumping speed and capacity of noble gas suitable to be used in several vacuum devices as for example sputter ion vacuum pumping systems comprising them as active element.

Подробнее
26-06-2014 дата публикации

BRANCHED LACTIC ACID POLYMERS WITH HIGH VISCOSITY IN THE MOLTEN STATE AND HIGH SHEAR SENSITIVITY, AND NANOCOMPOSITES THEREOF

Номер: US20140179893A1
Принадлежит:

Disclosed is a polymer obtainable by bulk polymerization of lactide or lactic acid or a lactic acid copolymer obtainable by copolymerization of lactide or lactic acid with glycolide, glycolic acid and/or hydroxyacids in open or closed (cyclic) form in the presence of at least two organic and/or organic/inorganic chain regulators or a functionalized nanoparticle (nanosilica, montmorillonite). 1. A homopolymer obtainable by bulk polymerization of lactide monomers or lactic acid or a copolymer obtainable by copolymerization of lactide monomers or lactic acid with glycolide monomers , glycolic acid and/or hydroxyacids in open or closed (cyclic) form , said polymerization or copolymerization being performed in the presence of at least two chain regulators or in the presence of at least one functionalized nanoparticle , optionally in combination with one or more chain regulators , the percentage by weight of the homo- or copolymer being at least 80% in the material obtained during polymerization.2. A polymer or copolymer as claimed in wherein the chain regulators are organic or organic-inorganic hybrids.3. A polymer or copolymer as claimed in wherein the chain regulators are selected from:a) at least two chain regulators having functional groups, one of which has at least two functional groups capable of reacting with functional groups of the other regulator or the monomer or both;b) at least one silica or one montmorillonite functionalized with silanes and at least one chain regulator, having at least one functional group capable of reacting with functional groups of the monomer or the silica or the montmorillonite functionalized with silanes, or both; andc) at least one silica or one montmorillonite functionalized with silanes containing reactive groups which can react with the growing polymer.4. A polymer or copolymer as claimed in claim 3 , wherein the chain regulators and/or the silica or the montmorillonite are present in amounts of between 0.01 and 20% in weight of ...

Подробнее
16-04-2015 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20150105402A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of allylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
28-04-2016 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20160113926A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
11-05-2017 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20170128442A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
14-06-2018 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20180161323A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
05-07-2018 дата публикации

Deep convolutional network heterogeneous architecture

Номер: US20180189229A1

Embodiments are directed towards a system on chip (SoC) that implements a deep convolutional network heterogeneous architecture. The SoC includes a system bus, a plurality of addressable memory arrays coupled to the system bus, at least one applications processor core coupled to the system bus, and a configurable accelerator framework coupled to the system bus. The configurable accelerator framework is an image and deep convolutional neural network (DCNN) co-processing system. The SoC also includes a plurality of digital signal processors (DSPs) coupled to the system bus, wherein the plurality of DSPs coordinate functionality with the configurable accelerator framework to execute the DCNN.

Подробнее
22-07-2021 дата публикации

ELONGATED MEMBER FOR A RACK

Номер: US20210222888A1
Принадлежит: WHIRLPOOL CORPORATION

A rack for a cooking appliance includes a perimeter rim that has a first end, a second end, a first side rail, and a second side rail. A plurality of spaced rails are disposed between each of the first and second rails and the first and second ends of the perimeter rim. An elongated member is operably coupled to the perimeter rim and is proximate to the plurality of spaced rails. A crossbar is disposed proximate to the elongated member. The crossbar defines an opening directly behind the elongated member along a length of the elongated member and a length of the crossbar. 1. A cooking appliance , comprising:a body defining a cavity and a plurality of retention rails; and a perimeter rim having a first end and a second end;', 'a plurality of spaced rails disposed between the first end and the second end of the perimeter rim; and', 'an elongated member including a display surface, an attachment surface, and an indicia disposed on the display surface, wherein the elongated member is operably coupled to a central region of the first end of the perimeter rim proximate to the plurality of spaced rails via the attachment surface and divides the first end at the central region., 'a rack operably coupled to the retention rails of the body within the cavity, the rack including2. The cooking appliance of claim 1 , wherein the elongated member is formed from an insulation material.3. The cooking appliance of claim 1 , wherein the elongated member includes retention features disposed on the attachment surface.4. The cooking appliance of claim 3 , wherein the elongated member is operably coupled to the perimeter rim of the rack via the retention features.5. The cooking appliance of claim 1 , wherein the display surface includes a first display surface and a second display surface claim 1 , and wherein the indicia is disposed on each of the first display surface and the second display surface.6. The cooking appliance of claim 1 , wherein the attachment surface defines a groove ...

Подробнее
02-10-2014 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20140296250A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
01-08-2019 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20190231774A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
13-08-2020 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20200253965A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
08-10-2015 дата публикации

METHOD OF PREPARATION OF METAXALONE

Номер: US20150284345A1

The present invention relates to a method of preparation of metaxalone comprising reaction of triglycidyl isocyanurate (TGIC) with m-xylenol, characterized in that said reaction is carried out in a solvent mixture comprising an aprotic polar solvent with dielectric constant greater than or equal to 30 and at least one other solvent selected from the group comprising apolar solvents and aprotic polar solvents with dielectric constant below 30 said solvent mixture comprising from 5 to 40 wt. % of said first solvent and from 95 to 60 wt. % of said second solvent, adding the TGIC at a temperature between 30° C. and 50° C., and after adding the TGIC, raising the temperature of the reaction solution to a value between 80° C. and 180° C. in a time between 120 and 180 minutes at a rate of increase not greater that 1.25° C. per minute. The invention also relates to a metaxalone with a reduced content of impurities derived from incomplete reactions and/or side reactions of the method of production. 2. The method of preparation of metaxalone according to claim 1 , characterized in that said aprotic polar solvent is selected from the group consisting of N-methylpyrrolidone claim 1 , dimethylformamide claim 1 , dimethylsulphoxide claim 1 , hexamethylphosphoramide claim 1 , dimethylacetamide and acetonitrile claim 1 , preferably N-methylpyrrolidone and dimethylformamide.3. The method of preparation of metaxalone according to claim 1 , characterized in that said apolar solvent is selected from the group consisting of cyclohexane claim 1 , heptane claim 1 , benzene claim 1 , toluene claim 1 , xylene claim 1 , mesitylene claim 1 , naphthalene claim 1 , chlorobenzene claim 1 , chloroxylene claim 1 , chloroform claim 1 , propyl ether claim 1 , isopropyl ether claim 1 , butyl ether claim 1 , pentyl ether claim 1 , benzylethyl ether claim 1 , tetrahydrofuran (THF) and 2-methyl tetrahydrofuran claim 1 , preferably toluene and xylene.4. The method of preparation of metaxalone according to ...

Подробнее
06-10-2016 дата публикации

Motor-compressor with stage impellers integrated in the motor-rotors

Номер: US20160290345A1
Принадлежит: Nuovo Pignone Srl

A shaftless motor-compressor is disclosed, comprising a casing and at least one compressor stage arranged in the casing. Each compressor stage comprises a respective impeller arranged for rotation in the casing around a rotation axis. Each impeller is combined with an embedded electric motor housed in the casing and comprised of a motor stator and a motor rotor. The motor stator of each compressor stage circumferentially surrounds the impeller and the motor rotor, integral with the impeller. The motor rotor of each stage is arranged inside the respective motor stator.

Подробнее
16-12-2021 дата публикации

Systems and methods for utilizing a machine learning model to identify public parking spaces and for providing notifications of available public parking spaces

Номер: US20210390856A1
Принадлежит: Verizon Connect Development Ltd

A device may receive geographical data identifying a geographical area, and may receive, from vehicle devices of vehicles, first vehicle data identifying engine off conditions, locations during engine off conditions, and durations of the engine off conditions. The device may divide, based on the geographical data, the geographical area into clusters with particular dimensions, and may process data identifying the clusters and the first vehicle data, with a machine learning model, to determine parking data identifying public parking spaces in the geographical area. The device may receive, from a set of the vehicle devices associated with vehicles parked in the public parking spaces, vehicle data identifying engine on conditions and locations during the engine on conditions, and may identify available public parking spaces based on the second vehicle data and the parking data. The device may perform one or more actions based on data identifying the available public parking spaces.

Подробнее
22-10-2015 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20150297589A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
10-11-2016 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20160324853A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29. A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31. A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33. A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34. A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35. A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
23-11-2017 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20170333425A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29: A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30: A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31: A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32: A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33: A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34: A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35: A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
29-10-2020 дата публикации

Cell bio-incubator with a variable internal pressure

Номер: US20200339937A1

A system for incubating one or more cells and/or organotypic cultures for biological investigation, in particular for toxicology assessment, comprising a bio-incubator and a pressure system fluidly connected with the bio-incubator. The pressure system is a cyclic gas pressure system configured for cyclically varying the gas pressure in the bio-incubator between a negative pressure and a positive pressure compared to the atmospheric pressure, so as to reproduce the pressure conditions in lungs of a living mammal. The system is remarkable in that the cyclic gas pressure system comprises a feedthrough with a pipe configured to deviate the air influx from the one or more cells and/or organotypic cultures.

Подробнее
13-12-2018 дата публикации

TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM

Номер: US20180353503A1

A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40° C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. 128-. (canceled)29: A pharmaceutical composition , comprising trazodone hydrochloride and at least one pharmaceutically acceptable excipient , wherein said trazodone hydrochloride comprises less than 15 ppm of alkylating substances.30: A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 10 ppm of alkylating substances.31: A pharmaceutical composition according to claim 29 , wherein said trazodone hydrochloride comprises less than 2.5 ppm of alkylating substances.32: A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is selected from the group consisting of antiadherents claim 29 , binders claim 29 , disintegrants claim 29 , fillers claim 29 , diluents claim 29 , flavouring agents claim 29 , colorants claim 29 , fluidizers claim 29 , lubricants claim 29 , preservatives claim 29 , moistening agents claim 29 , absorbents claim 29 , and sweeteners.33: A pharmaceutical composition according to claim 29 , wherein said at least one pharmaceutically acceptable excipient is a sugar.34: A pharmaceutical composition according to claim 33 , wherein said sugar is selected from the group consisting of lactose claim 33 , glucose and sucrose.35: A pharmaceutical composition according to claim 29 , wherein said ...

Подробнее
28-12-2017 дата публикации

ANTIBACTERIAL COMPOUNDS

Номер: US20170368017A1

The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials. 1: A compound of formula (I){'br': None, 'sub': 1', '2', '3, 'A-L-B-L-Y-L-C\u2003\u2003(I)'} A is a 10-membered fused bicyclic ring;', {'sub': 1', '1-3, 'Lis σ bond, —O— or —N(R′)—, wherein R′ is H or (C)alkyl;'}, 'B is a divalent residue of a piperazine or piperidine ring;', {'sub': 2', '2', '1-3, 'Lis σ bond, —CH—, —O—, or —N(R′)—, wherein R′ is H or (C)alkyl;'}, {'sub': 1-6', '2-6', '2-6', '3-6', '1-3', '3-6', '1-3, 'Y is a (C)alkylenyl, (C)alkenylenyl, (C)alkynylenyl, or (C)cycloalkylenyl group, said group being optionally substituted with one or more groups selected from —OH, (C)alkyl, (C)cycloalkyl, 3- to 5-membered oxacycloalkyl, —COOR′, —NR′R″ wherein R′ and R″, identical or different each other, are hydrogen atom or (C)alkyl,'}, {'sub': 3', '2', '2', '1-6', '1-6', '2', '2', '1-3, 'Lis —O—, —(CH)—, —N(R′)—, —N(R′)—C(═O)—, —N(R′)—C(═S)—, —N(R′)—(C)alkylenyl-, —C(═O)—N(R′)—, —C(═O)—N(R′)—(C)alkylenyl-, —SO—N(R′)—, —N(R′)—SO—, wherein R′ is hydrogen atom or (C)alkyl;'}, 'C is a group having a 5- or 6-membered saturated or unsaturated ring, or a 9- or 10-membered fused bicyclic ring;', 'or an addition salt with a pharmaceutically acceptable organic or inorganic acid or base, an enantiomer, N-oxide, or quaternary ammonium salt of said compound of formula (I)., 'wherein'}5: The compound according to claim 4 , wherein Rand Rtogether form a ring selected from the group consisting of benzene claim 4 , furan claim 4 , tetrahydrofuran claim 4 , dioxolane claim 4 , piperidine and piperazine.6: The compound according to claim 4 , wherein Rand R claim 4 , equal or different each other claim 4 , are a hydrogen atom or an aryl group claim 4 , or together form a ring selected from the group consisting of benzene claim 4 , pyridine claim 4 , and piperidine.8: The compound according to claim 1 , wherein said Y is a (C)alkylenyl claim 1 , ...

Подробнее
28-12-2017 дата публикации

ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY

Номер: US20170369450A1

The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials. 4: The compound according to claim 1 , wherein G3 is N claim 1 , CH or C(CH).5: The compound according to claim 1 , wherein Ris hydrogen atom claim 1 , halogen atom claim 1 , cyano claim 1 , (C)alkyl or NR′R″ claim 1 , wherein R′ and R″ are hydrogen atom or (C)alkyl.6: The compound according to claim 1 , wherein Ris hydrogen atom claim 1 , F claim 1 , Cl claim 1 , cyano claim 1 , CH claim 1 , NHor N(CH).7: The compound according to claim 1 , wherein said Ris hydrogen atom claim 1 , fluorine atom claim 1 , chloride atom claim 1 , OH claim 1 , (C)alkyl-OH claim 1 , —COOR′ or —CON(R′)(R″) claim 1 , wherein R′ and R″ claim 1 , identical or different each other claim 1 , are hydrogen atom or (C)alkyl.8: The compound according to claim 1 , wherein said Ris hydrogen atom claim 1 , halogen atom claim 1 , cyano claim 1 , (C)alkyl claim 1 , (C)alkoxy claim 1 , or NR′R″ claim 1 , wherein R′ and R″ claim 1 , identical or different each other claim 1 , are hydrogen atom or (C)alkyl.9: The compound according to claim 1 , wherein said Y is (C)alkylenyl group claim 1 , —NH—(C)alkylenyl group or (C)cycloalkylenyl group claim 1 , said group being optionally substituted with one hydroxy group or an amino group.10: The compound according to claim 1 , wherein said Pis O claim 1 , S claim 1 , SOor CH.11: The compound according to claim 1 , wherein said Rand Rtogether form a 5- or 6-membered aromatic or aliphatic ring claim 1 , optionally comprising at least one heteroatom selected from N claim 1 , O and S claim 1 , wherein said ring optionally bears an oxo group.12: The compound according to claim 11 , wherein Rand Rtogether form a 6-membered ring selected from benzene or pyridine.13: A pharmaceutical composition claim 1 , comprising at least one compound of formula (I) according to claim 1 , a salt thereof with a pharmaceutically acceptable organic ...

Подробнее
15-07-2011 дата публикации

Process for the preparation of delmopinol and derivatives thereof

Номер: MY143867A
Принадлежит: Sinclair Pharmaceuticals Ltd

PROCESS FOR THE PREPARATION OF DELMOPINOL AND DERIVATIVES THEREOF A PROCESS FOR THE PREPARATION OF DELMOPINOL (3-(4-PROPYLHEPTYL)-4-MORPHOLINETHANOL) OR A DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT, OR A SOLVATE THEREOF, INCLUDING AN HYDRATE, COMPRISES REACTING OXAZOLIDIN (2, 3-C] MORPHOLINE AND A GRIGNARD REAGENT, AND OPTIONALLY CONVERTING THE DELMOPINOL (OR DERIVATIVE) FREE BASE INTO A PHARMACEUTICALLY ACCEPTABLE SALT. THE OXAZOLIDIN [2, 3-CL MORPHOLINE AND THE GRIGNARD REAGENT ARE USEFUL AS INTERMEDIATES IN THE PRODUCTION PROCESS.

Подробнее
19-07-2016 дата публикации

Vegetable oil derivatives as extender oils for elastomer compositions

Номер: US9394426B2
Принадлежит: Novamont SpA

Elastomer composition comprising at least one elastomer and at least one vegetable oil derivative selected from one or more of: a. mixture of triglycerides comprising one or more of the following oligomeric structures: R 4 [OC(O)R 1 C(O)OCH 2 CH(OR 2 )CH 2 ] n OR 3 and said mixture of triglycerides having a Numerical Average Molecular Weight (Mn) of between 800 and 10,000, b. triglycerides of one or more long chain carboxylic acids including at least one carboxylic acid containing adjacent hydroxyl groups, c. esters of polyols with at least a monocarboxylic acid and at least a dicarboxylic acid, the said esters being other than triglycerides.

Подробнее
26-01-2021 дата публикации

elastomeric compositions, vulcanized product prepared from elastomeric compositions and respective use

Номер: BR112014031078B1
Принадлежит: Novamont S.p.A.

COMPOSIÇÕES ELASTOMÉRICAS, PRODUTO VULCANIZADO PREPARADO A PARTIR DE COMPOSIÇÕES ELASTOMÉRICAS E RESPECTIVO USO A presente invenção se refere a composições elastoméricas contendo derivados vegetais, tais como biocargas e derivados de óleo vegetal que atuam como óleos de diluição. Em particular, um objetivo da presente invenção são composições elastoméricas que compreendem pelo menos um elastômero, pelo menos um derivado de óleo vegetal, pelo menos uma biocarga de origem vegetal e pelo menos um agente de acoplamento. ELASTOMERIC COMPOSITIONS, VULCANIZED PRODUCT PREPARED FROM ELASTOMERIC COMPOSITIONS AND THEIR RESPECTIVE USE The present invention relates to elastomeric compositions containing vegetable derivatives, such as biocharges and vegetable oil derivatives that act as dilution oils. In particular, an object of the present invention is elastomeric compositions that comprise at least one elastomer, at least one derived from vegetable oil, at least one biocharge of vegetable origin and at least one coupling agent.

Подробнее
12-05-1999 дата публикации

Process for the hydrogenation of diene (co)polymers

Номер: EP0914867A1
Принадлежит: Enichem SpA

Catalytic composition effective in the hydrogenation of olefinic double bonds prepared by reaction between: (A) at least one cyclopentadienyl complex of a transition metal having general formula (I) (R)(R 1 )M 1 (R 2 )(R 3 ) wherein R is an anion containing an η 5 -cyclopentadienyl ring coordinated to M 1 ; M 1 is selected from titanium, zirconium and hafnium; R 2 and R 3 , the same or different, are organic or inorganic anion groups bound to M 1 ; R 1 is selected from cyclopentadienyl and R 2 ; (B) an alkylating composition essentially consisting of: (b1) an organometallic compound having general formula (II) M 2 (R 4 )(R 5 ), wherein M 2 is selected from Zn and Mg; (b2) an organoderivative of aluminum having general formula (III) Al(R 6 ) 3 .

Подробнее
08-05-2001 дата публикации

Process for the hydrogenation of diene (co)polymers

Номер: US6228952B1
Принадлежит: Enichem SpA

Catalytic composition effective in the hydrogenation of olefinic double bonds prepared by reaction between:(A) at least one cyclopentadienyl complex of a transition metal having general formula (I) (R)(R1)M1(R2)(R3) wherein R is an anion containing an eta5-cyclopentadienyl ring coordinated to M1; M1 is selected from titanium, zirconium and hafnium; R2 and R3, the same or different, are organic or inorganic anion groups bound to M1; R1 is selected from cyclopentadienyl and R2;(B) an alkylating composition essentially consisting of:(b1) an organometallic compound having general formula (II) M2 (R4)(R5), wherein M2 is selected from Zn and Mg;(b2) an organoderivative of aluminum having general formula (III) Al(R6)3.

Подробнее
30-07-2003 дата публикации

Process for the hydrogenation of diene (co)polymers

Номер: EP0914867B1
Принадлежит: Polimeri Europa SpA

Подробнее
11-11-1987 дата публикации

Perfluoropolyethers free from peroxidic oxygen and containing perfluoroepoxy groups positioned along their perfluoropolyether chain

Номер: EP0244839A2
Принадлежит: Ausimont SpA

Perfluoropolyethers having fluorinated epoxy groups positioned along their perfluoropolyether chain, and free from peroxidic oxygen, are obtained by means of a low-temperature oxidation process, in the liquid phase, with molecular oxygen and in the presence of U.V. light, of a mixture of a perfluorinated monoolefin and a perfluorinated conjugated diene, and by the subsequent photochemical decomposition of the peroxy groups contained in the photooxidation product, carried out by treating the peroxy-groups containing product with U.V. light at a temperature of from 0°C to 160°C. Derivatives of said epoxy containing perfluoropolyethers in which the epoxy groups have been converted to functional groups are also disclosed.

Подробнее
11-11-1997 дата публикации

ELASTOMERIC COMPOSITION USEFUL AS A TREAD FOR TIRES

Номер: IT1277581B1
Принадлежит: Enichem Elastomers

Подробнее
25-04-2006 дата публикации

A process for the preparation of low branch content polybutadiene

Номер: CA2524017A1
Принадлежит: Polimeri Europa SpA

A process for the preparation of low branch content polybutadiene comprising: (a) a first butadiene polymerisation stage; (b) treatment of the polymer solution obtained upon completion of stage (a) with a coupling agent selected from: (i) polyunsaturated natural oils; (ii) butadiene and/or isoprene oligomers; (iii) butadiene and/or isoprene co-polymers with vinylarene monomers; the unsaturations present in compounds (i) - (iii) being at least partially substituted with groups selected from epoxides, anhydrides and esters; (c) recovery of the low branch content polybutadiene obtained upon completion of stage (b)

Подробнее
04-01-1998 дата публикации

Process for the preparation of a catalyst useful for the hydrogenation of styrene-butadiene copolymers

Номер: CA2209428A1

Catalytic composition effective in the selective hydrogenation of olefinic double bonds prepared by the reaction between: (A) at least one bis(cyclopentadienyl)Titanium derivative having the general formula (I) (C5H5)2Ti(R)(R1) wherein R and R1, the same or different, are halogens; the above compound (I) being solid or dispersed in one or more non-solvent diluents; (B) at least one organo derivative having general formula (II) M(R2)(R3), wherein M is selected from Zinc and Magnesium, preferably Magnesium, and R2 and R3, the same or different, are selected from C1-C16 alkyls; (C) at least one modifier.

Подробнее
06-04-1988 дата публикации

Programming and control panel for dry-cleaning machines

Номер: EP0262584A2
Автор: Tommaso Arbizzani
Принадлежит: Sodibo SpA

Programming and control panel for dry-cleaning machines comprising: a schematic illustration (2) of elements of a dry-cleaning machine marked by first warning lights (3,4) adapted to indicate alarm or operative conditions, second warning lights (5) corresponding to various steps of a washing cycle, a digital display (6) cooperating with third warning lights (7) to visualize selected adjustments and operative conditions of the washing cycle, a plurality of buttons (8) by means of which it is possible to vary the adjustments and operative conditions of the washing cycle.

Подробнее
03-11-1962 дата публикации

Automatic device for igniting, regulating and extinguishing gas burners, in particular for water heaters

Номер: FR1308510A
Автор: Tommaso Farinella
Принадлежит:

Подробнее
01-12-1967 дата публикации

Improvement with mussels for baking pies

Номер: FR1503769A
Принадлежит:

Подробнее
15-11-2022 дата публикации

Motor-compressor with stage impellers integrated in the motor-rotors

Номер: CA2930473C
Принадлежит: Nuovo Pignone Technologie Srl

A shaftless motor-compressor (1) is disclosed, comprising a casing (3) and at least one compressor stage (9A, 9B) arranged in the casing. Each compressor stage comprises a respective impeller (11A, 11B) arranged for rotation in the casing (3) around a rotation axis (A-A). Each impeller (11A, 11B) is combined with an embedded electric motor (13A, 13B) housed in the casing (3) and comprised of a motor stator (15A, 15B) and a motor rotor (17A, 17B). The motor stator (15A, 15B) of each compressor stage (9A, 9B) circumferentially surrounds the impeller (11A, 1B) and the motor rotor (17A, 17B), integral with the impeller. The motor rotor (17A, 17B) of each stage (9A, 9B) is arranged inside the respective motor stator.

Подробнее
17-12-1993 дата публикации

Anti-intrusion system

Номер: IT1240570B
Принадлежит: Bitron Video

Подробнее
07-09-2013 дата публикации

PROCEDURE FOR THE DEVULCANIZATION OF VULCANIZED FLUOROELASTOMERS, FLUOROELASTOMERS SO OBTAINED AND THEIR USE

Номер: ITMI20120339A1

A process for devulcanizing fluoroelastomers having a fluorine content between 62% and 74% by weight vulcanized by ionic systems, preferably selected from bisphenol A and bisphenol AF, i.e. 2,2-bis(4-hydroxyphenyl)hexafluoropropane, said process being characterized in that it comprises a step of heating said vulcanized fluoroelastomers in the presence of a hydrolysis composition consisting of one or more chemical selected from water, water soluble alcohols, water soluble glycols and mixtures thereof, at a temperature from 350°C to 430°C. Fluoroelastomers obtainable by said process and their use for the preparation of compounds and vulcanized compositions are also described.

Подробнее
08-11-1989 дата публикации

Apparatus for extracting solvent from mixtures with oils, greases and impurities for dry-cleaning machines

Номер: EP0340482A2
Автор: Tommaso Arbizzani
Принадлежит: SO DI BO SpA

Apparatus for extracting solvent from mixtures with oils, greases and impurities for dry-cleaning machines, consisting of a tank (2) which downwardly defines a part for containing the mixture, a pack of disks (4) being mounted in said tank and rotatably actuated according to a substantially horizontal axis (3), said disks being adapted to immerse in and re-emerge above the mixture by rotating, the upper part of said tank having an air-solvent outlet (19) and an air inlet (20) mutually joined by a solvent condensing assembly (22) comprising a refrigeration radiator (24) overlying a tray (23) for collecting the condensed solvent and a fan (26) to make the air flow through the assembly, said airflow being adapted to evaporate the solvent from the re-emerging semi-portions of the disks.

Подробнее
16-01-2008 дата публикации

Turbocharger with catalytic coating

Номер: EP1878879A1

A compressor (1) comprises a compressor wheel (3), a gas inlet housing (2), and a catalytic coating (7) which at least partially reduces deposits of dirt on a flow-guiding portion. The flow-guiding portion is at least partially provided with the catalytic coating. A compressor comprises a compressor wheel, a gas inlet housing, and a catalytic coating which at least partially reduces deposits of dirt on a flow-guiding portion. The flow-guiding portion is at least partially provided with the catalytic coating. The catalytic coating comprises oxide(s) of transition metal(s) chosen from copper, silver, zinc, cadmium, mercury, scandium, yttrium, titanium, zirconium, hafnium, vanadium, niobium, tantalum, chromium, molybdenum, tungsten, manganese, technetium, rhenium, iron, ruthenium, osmium, cobalt, rhodium, iridium, nickel, palladium and platinum. The catalytic coating comprises an oxide of mixture of transition metal(s) and metal(s), preferably aluminum, and/or semimetal, preferably silicon. The mixture comprises (in at%) aluminum (57-85, preferably 71), iron (6.9-10.4, preferably 8.7), chromium (8.5-12.7, preferably 10.6), and copper (7.8-11.6, preferably 9.7). An independent claim is included for production of compressor.

Подробнее
08-02-1984 дата публикации

Heat recovery system for a dry cleaner drying and deodorizing circuit

Номер: EP0100082A2
Автор: Tommaso Arbizzani
Принадлежит: Donini International SpA

An improved heat recovery system for a dry cleaner drying and deodorizing circuit is described, which can afford substantial energy savings during the drying step and the deodorizing step of the articles of clothing being cleaned.The system comprises two condensers (12, 13) located in a conduit (5) connecting the air outlet (4) and inlet (3) of a drum (2), between an evaporator (8) and a heating battery (11) for delivering heat to the air prior to its re-introduction into the drum (2). Advantageously one (12) of the condensers is of the water-cooled type.

Подробнее
15-11-2022 дата публикации

Systems and methods for detecting vehicle tailgating

Номер: US11501538B2
Принадлежит: Verizon Connect Development Ltd

A device may obtain video data associated with a driving event involving a first vehicle. The device may determine a vanishing point associated with the video data and may construct a cone of impact of the first vehicle based on the vanishing point. The device may detect a second vehicle within the cone of impact and may analyze the subset of video frames to determine a distance between the first vehicle and the second vehicle. The device may determine a speed of the first vehicle during a time period associated with a subset of video frames. The device may determine a headway score, representative of a severity associated with the first vehicle being within a proximity threshold of the second vehicle during the time period, based on the distance and the speed. The device may determine an occurrence of a tailgating event based on the headway score.

Подробнее
25-07-1990 дата публикации

"BRANCHED AND HYDROGENATED BLOCK COPOLYMER AND PROCEDURES FOR ITS PREPARATION"

Номер: IT9021042D0
Принадлежит: Enichem Elastomers

Подробнее
31-05-2021 дата публикации

Process for extracting latex, resin and rubber from guayule plants

Номер: RS61700B1
Принадлежит: Versalis Spa

Подробнее
20-11-1997 дата публикации

Hydrogenated and branched block copolymer and process for its manufacture

Номер: DE69124869T2
Принадлежит: Enichem Elastomers Ltd

Подробнее
22-04-1992 дата публикации

Branched and hydrogenated block copolymer and process for its preparation

Номер: EP0471999A3
Принадлежит: Enichem Elastomeri SpA

Подробнее
12-04-2017 дата публикации

ANTIBACTERIAL COMPOUNDS WITH ACTION ON TOPOISOMERASES

Номер: AR103028A1
Принадлежит: Acraf

La presente se refiere a compuestos antibacterianos, a composiciones farmacéuticas que los contienen, y a su uso como antimicrobianos. Reivindicación 1: Compuesto de fórmula (1): A-L¹-B-L²-Y-L³-C (1) en la que A es un anillo bicíclico condensado de 10 miembros; L¹ es un enlace s, -O- o -N(R)-, en el que R es H o alquilo C₁₋₃; B es un resto divalente de un anillo piperazínico o piperidínico; L² es un enlace s, -CH₂-, -O-, o -N(R)-, en el que R es H o alquilo C₁₋₃; Y es un grupo alquilenilo C₁₋₆, alquenilenilo C₂₋₆, alquinilenilo C₂₋₆, o cicloalquinilenilo C₃₋₆, estando dicho grupo opcionalmente sustituido con uno o más grupos seleccionados de -OH, alquilo C₁₋₃, cicloalquilo C₃₋₆, oxacicloalquilo de 3 a 5 miembros, -COOR, -NRR, en los que R y R, idénticos o diferentes entre sí, son un átomo de hidrógeno o alquilo C₁₋₃; L³ es -O-, -(CH₂)₂-, -N(R)-, -N(R)-C(=O)-, -N(R)-C(=S)-, -N(R)-alquilenilo C₁₋₆-, -C(=O)-N(R)-, -C(=O)-N(R)-alquilenilo C₁₋₆-, -SO₂-N(R)-, -N(R)-SO₂-, en los que R es un átomo de hidrógeno o alquilo C₁₋₃; C es un grupo que tiene un anillo saturado o insaturado de 5 ó 6 miembros, o un anillo bicíclico condensado de 9 ó 10 miembros; sales de adición con ácidos o bases orgánicos o inorgánicos farmacéuticamente aceptables, enantiómeros, N-óxidos y sales de amonio cuaternario de dicho compuesto de fórmula (1).

Подробнее
15-02-2017 дата публикации

Tyre for heavy load vehicle wheels

Номер: EP2655094B1
Принадлежит: Pirelli SpA, Pirelli Tyre SpA

Подробнее
24-04-2018 дата публикации

Antibacterial compounds having broad spectrum of activity.

Номер: MX2017007371A
Принадлежит: Acraf

La presente invención se refiere a novedosos compuestos antibacterianos, a composiciones farmacéuticas que los contienen, y a su uso como antimicrobianos.

Подробнее
28-05-2019 дата публикации

Vector velocity estimation using transverse oscillation (TO) and synthetic aperture sequential beamforming (SASB)

Номер: US10302752B2
Принадлежит: BK Medical AS

An ultrasound imaging system includes a transducer array with a plurality of transducer elements configured to repeatedly emit in a predetermined pattern, a first beamformer configured to beamform echo signals received by the transducer array to produce a low resolution line of data for each emission, and a first communication interface configured to wirelessly transmit the low resolution lines of data for each emission in series. The ultrasound imaging system further includes a second communication interface configured to for each emission in series wirelessly receive the transmitted low resolution lines of data, a second beamformer configured to beamform the received low resolution lines of data to produce high resolution ultrasound data, and a velocity processor configured to estimate vector velocity components from the high resolution ultrasound data in a lateral direction and an axial using an autocorrelation algorithm.

Подробнее
25-01-2005 дата публикации

Injectable pure formulation of anesthetic compound.

Номер: DZ2503A1
Автор: Vicenzo De Tommaso
Принадлежит: Saucy Ltd

Подробнее
24-08-2005 дата публикации

Support for colour cathode ray tube frame/mask assembly

Номер: EP1565927A2
Принадлежит: Thomson Licensing SAS

Tube à rayons cathodiques en couleurs comportant un ensemble cadre/masque disposé à l'intérieur du tube, ledit ensemble cadre/masque étant maintenu en place dans le tube grâce à des moyens de support comprenant un premier bras (48), soudé à une première extrémité(53) au cadre, et un deuxième bras(46), formant ressort, dont une première extrémité(50) comporte une ouverture (55) destinée à coopérer avec un pion solidaire de l'enveloppe en verre du tube à rayons cathodiques et dont la deuxième extrémité (51) est soudée à la deuxième extrémité (54) du premier bras, les deux bras s'étendant de façon à ce que leur première extrémité (50,53) soient disposées sensiblement l'une face à l'autre, lesdits éléments de support comportant en outre une langue (60), solidaire du cadre, et s'étendant en direction de l'extrémité du deuxième bras de manière à pouvoir traverser cette extrémité au travers d'une ouverture (61) pratiquée dans ladite extrémité.

Подробнее
21-09-2021 дата публикации

Improved gas burner

Номер: ES2854279T3
Принадлежит: EGO Elektro Geratebau GmbH

Quemador de gas con al menos dos anillos de llamas, que consiste en: - un portainyector (6) provisto de un único inyector vertical (22) situado de forma centrada en la base de dicho portainyector (6), - un divisor de llama (4) con una cámara exterior (26) de desarrollo generalmente anular, y una cámara interior (28) de desarrollo generalmente circular, entre las que se interpone una cavidad anular (29), - una cubierta (8), y en dicho quemador de gas: - dicho divisor de llama (4) comprende en su parte inferior medios de apoyo (30, 23) de dicho divisor de llama sobre dicho portainyector (6, 12) y su conexión con este, - la cámara circular interior (28) de dicho divisor de llama (4) comprende un único canal sustancialmente vertical (46) enfrentado a dicho único inyector vertical (22) de dicho portainyector (6), abriéndose dicho conducto sustancialmente vertical (46) en una cámara radial (47) de efecto Venturi definida en dicha cámara interior (28) del divisor de llama (4) y limitada por arriba por la porción discoidal central (54) de dicha cubierta (8), - dicho divisor de llama (4) comprende al menos un canal sustancialmente radial (36) para la conexión fluida entre dicha cámara circular interior (28) y dicha cámara anular exterior (26), estando dicho canal radial (36) cerrado por arriba por una correspondiente parte radial (56) de dicha cubierta (8), - dichos al menos dos anillos de llamas comprendiendo un primer anillo de llamas, generado en los orificios (42, 43) provistos en la pared exterior (32) de dicha cámara anular exterior (26) del divisor de llama (4) y al menos un segundo anillo de llamas que puede generarse en los orificios (42, 43) provistos en la pared interior (34) de dicha cámara anular exterior (26) del divisor de llama (4), o en los orificios (42, 43) provistos en la pared lateral (35) de dicha cámara interior (28) del divisor de llama (4) o en los orificios (42, 43) provistos tanto en la pared interior (34) de dicha cámara anular exterior (26) como ...

Подробнее
04-09-2007 дата публикации

Process for the hydrogenation of diene (co)polymers

Номер: CA2250493C
Принадлежит: Enichem SpA

Catalytic composition effective in the hydrogenation of olefinic double bonds prepared by reaction between: (A) at least one cyclopentadienyl complex of a transi- tion metal having general formula (I) (R) (R1) M1 (R2) (R3) wherein R is an anion containing an n5-cyclopentadienyl ring coordinated to M1; M1 is selected from titanium, zirconium and hafnium; R2 and R3, the same or different, are organic or inorganic anion groups bound to M1; R1 is selected from cyclopentadienyl and R2; (B) an alkylating composition essentially consisting of: (b1) an organometallic compound having general formula (II) M2 (R4) (R5) , wherein M2 is selected from Zn and Mg; (b2) an organoderivative of aluminum having general formula (III) Al (R6)3.

Подробнее
19-01-1926 дата публикации

Control mechanism with high vacuum for mechanical pianos

Номер: FR599710A
Автор: Tommaso Taliani
Принадлежит:

Подробнее
24-11-2016 дата публикации

Centrifugal compressor impeller and compressor comprising said impeller

Номер: CA2984878A1
Принадлежит: Nuovo Pignone Technologie Srl

A Centrifugal compressor impeller (4) comprising a plurality of blades (6) extending from an hub (7), each blade having a first wall (6A) defining a pressure side of the blade, and a second wall (6B) defining a suction side of the blade, and a free end defining a tip (6C) of the blade, the tip (6C) presenting a raised rim (8) aligned to the first wall (6A), the second wall (6B) of the blade being at least partially aligned with a surface (6D) of the tip (6C) free from said raised rim (8).

Подробнее
10-11-1997 дата публикации

ADHESIVE COMPOSITION FOR NON-FABRICS BASED ON BLOCK COPOLYMERS

Номер: IT1277437B1
Принадлежит: Enichem Elastomeri Srl

Подробнее
14-05-1992 дата публикации

ANTI-INTRUSION SYSTEM

Номер: IT9067888A1
Принадлежит: Bitron Video

Подробнее
28-02-1992 дата публикации

BLOCK COPOLYMER, HYDROGENATED AND BRANCHED, AND PROCEDURE FOR ITS PREPARATION

Номер: MX9100348A
Принадлежит: Enichem Elastomers

Подробнее
15-04-2004 дата публикации

Process for the hydrogenation of diene (co) polymers

Номер: DE69816753T2
Принадлежит: Polimeri Europa SpA

Подробнее
12-04-2023 дата публикации

Tyre for vehicle wheels with notched gripping elements

Номер: EP3941762B1
Автор: Tommaso Pizzorno
Принадлежит: Prometeon Tyre Group SRL

Подробнее
01-05-1992 дата публикации

PROCEDURE FOR THE PREPARATION OF FUNCTIONALIZED PERFLUOROPOLIETERES.

Номер: ES2026447T3
Принадлежит: Ausimont SpA

A process is disclosed for cracking high molecular weight perfluoropolyethers having neutral end groups obtained from the photooxidation of perfluoroolefins or the fluorination of hydrogenated polyalkylene oxides or by polymerization with opening of the partially fluorinated oxetane ring, said process being carried out in the presence of catalysts composed of fluorides, oxyfluorides or oxides of transi­tion metals or of Al, Sn, Sb at temperatures of from 150 to 380°C. The cracking process leads to the formation of low molecular weight perfluoropolyethers having neutral and acid end groups. The perfluoropolyether acids may be converted to functionalized perfluoropolyethers and are useful to produce new polymers.

Подробнее
06-07-2021 дата публикации

Centrifugal compressor impeller and compressor comprising said impeller

Номер: US11053951B2
Принадлежит: Nuovo Pignone Srl

A Centrifugal compressor impeller including a plurality of blades extending from a hub, each blade having a first wall defining a pressure side of the blade, and a second wall defining a suction side of the blade, and a free end defining a tip of the blade, the tip presenting a raised rim aligned to the first wall, the second wall of the blade being at least partially aligned with a surface of the tip free from the raised rim.

Подробнее
13-02-2013 дата публикации

Process for the preparation of polybutadiene with a low branching degree

Номер: EP1557433B1
Принадлежит: Versalis Spa

Подробнее
06-12-2018 дата публикации

Modular compressor with gas bearings and system for raising the pressure in production gas

Номер: AU2017272386A1
Принадлежит: VETCO GRAY SCANDINAVIA AS

A system and modular compressor (1) for raising the pressure in production gas is disclosed, wherein in a set of compressor modules each second module is a rotor module (4) carrying an impeller (5) driven in rotation relative to an adjacent stationary module (6), a rotor module and a stationary module in combination providing a compressor stage in which production gas is accelerated through a flow duct (7) that passes an interface (8) between the rotor module and the stationary module, wherein at said interface at least one bearing for axial and/or radial load is provided for journaling the rotor module on the stationary module. The at least one bearing is a gas bearing (15, 15 ', 34), wherein a passage (24; 27) is arranged in the stationary module (6) to lead an extracted portion of production gas at raised pressure from the compressor (1) to the gas bearing(s) (15, 15', 34).

Подробнее
12-08-2011 дата публикации

Process for the preparation of branched polybutadiene with a high content of 1,4-cis units

Номер: HK1147507A1
Принадлежит: Versalis Spa

Подробнее
23-09-1987 дата публикации

HULL WITH AEROHYDRODYNAMIC SYSTEM

Номер: IT1181362B
Автор: Tommaso Zavone
Принадлежит: Tommaso Zavone

Подробнее
27-06-1912 дата публикации

Improvements to airplanes and similar devices

Номер: FR439947A
Автор: Tommaso Sarri
Принадлежит: Tommaso Sarri

Подробнее
20-09-2021 дата публикации

DISTRIBUTOR OF DETERGENTS OR DISINFECTANTS AND RELATIVE SUPPORT SHELF.

Номер: IT202000005962A1
Автор: Tommaso Pacini
Принадлежит: La Bottega Dellalbergo S P A

Подробнее